NEVOLA, RICCARDO
 Distribuzione geografica
Continente #
EU - Europa 2.654
AS - Asia 1.294
NA - Nord America 1.001
SA - Sud America 187
Continente sconosciuto - Info sul continente non disponibili 61
AF - Africa 15
OC - Oceania 1
Totale 5.213
Nazione #
RU - Federazione Russa 2.029
US - Stati Uniti d'America 952
SG - Singapore 412
CN - Cina 278
IT - Italia 274
VN - Vietnam 217
HK - Hong Kong 168
BR - Brasile 156
IE - Irlanda 105
DE - Germania 78
KR - Corea 69
IN - India 48
JP - Giappone 37
CA - Canada 28
NL - Olanda 28
GB - Regno Unito 24
FR - Francia 23
FI - Finlandia 20
BD - Bangladesh 14
PL - Polonia 14
MX - Messico 13
ES - Italia 11
AR - Argentina 9
CZ - Repubblica Ceca 9
AT - Austria 8
TR - Turchia 8
CO - Colombia 6
ID - Indonesia 6
BE - Belgio 5
EC - Ecuador 5
MA - Marocco 5
PT - Portogallo 5
IQ - Iraq 4
LT - Lituania 4
UA - Ucraina 4
ZA - Sudafrica 4
BO - Bolivia 3
CH - Svizzera 3
SA - Arabia Saudita 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
CL - Cile 2
DO - Repubblica Dominicana 2
HN - Honduras 2
HR - Croazia 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
MO - Macao, regione amministrativa speciale della Cina 2
NP - Nepal 2
PK - Pakistan 2
SE - Svezia 2
TH - Thailandia 2
TW - Taiwan 2
UY - Uruguay 2
UZ - Uzbekistan 2
AL - Albania 1
AU - Australia 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DM - Dominica 1
EG - Egitto 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
LY - Libia 1
MD - Moldavia 1
MY - Malesia 1
OM - Oman 1
PE - Perù 1
PY - Paraguay 1
RO - Romania 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TJ - Tagikistan 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
Totale 5.152
Città #
Moscow 728
Singapore 193
San Jose 182
Hong Kong 164
Dublin 104
Santa Clara 85
Ashburn 81
Hefei 81
Naples 74
Ho Chi Minh City 67
Seoul 67
The Dalles 64
New York 57
Hanoi 52
Chandler 45
Bengaluru 37
Munich 33
Dallas 30
Beijing 25
Los Angeles 23
Amsterdam 18
Da Nang 17
Milan 15
São Paulo 14
Frankfurt am Main 13
Helsinki 12
Montreal 12
Boardman 10
Chicago 10
Florence 10
Haiphong 10
Orem 10
Phoenix 9
Atlanta 8
Falkenstein 8
Warsaw 8
Bremen 7
Cambridge 7
Guastalla 7
Liveri 7
Rome 7
Hillsboro 6
London 6
Princeton 6
Roxbury 6
Toronto 6
Belo Horizonte 5
Brooklyn 5
Brussels 5
Buffalo 5
Ercolano 5
Lappeenranta 5
Memphis 5
Mexico City 5
Nuremberg 5
Paris 5
Shanghai 5
Thái Nguyên 5
Tokyo 5
Bexley 4
Boston 4
Chennai 4
Council Bluffs 4
Dhaka 4
Hải Dương 4
Istanbul 4
Mumbai 4
Prague 4
Seattle 4
Ankara 3
Aversa 3
Baghdad 3
Beaverton 3
Boydton 3
Brasília 3
Brno 3
Can Tho 3
Casablanca 3
Eboli 3
Genoa 3
Kingston 3
La Paz 3
Phủ Lý 3
Piscataway 3
Quito 3
Quận Bình Thạnh 3
Salerno 3
Salvador 3
San Francisco 3
Secaucus 3
Shenzhen 3
Tianjin 3
Turku 3
Vienna 3
Wroclaw 3
Yên Bái 3
Afragola 2
Araguatins 2
Baku 2
Banda Aceh 2
Totale 2.635
Nome #
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 202
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 185
Non-invasive respiratory support in SARS-CoV-2 related acute respiratory distress syndrome: when is it most appropriate to start treatment? 184
Predictors of in-hospital mortality of COVID-19 patients and the role of telemetry in an internal medicine ward during the third phase of the pandemic 167
Epidemiology of HCV and HBV in a High Endemic Area of Southern Italy: Opportunities from the COVID-19 Pandemic—Standardized National Screening or One Tailored to Local Epidemiology? 166
Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease 165
COVID-19 and arrhythmia: The factors associated and the role of myocardial electrical impulse propagation. An observational study based on cardiac telemetric monitoring 164
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 160
HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis 159
Predictors of early and late hepatocellular carcinoma recurrence 156
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 154
Metabolic dysfunction-associated steatotic liver disease (MASLD): a systemic disease with a variable natural history and challenging management 153
Factors affecting long-term changes of liver stiffness in direct-acting anti-hepatitis C virus therapy: a multicenter prospective study 153
Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19 153
Remdesivir plus dexamethasone versus dexamethasone alone for the treatment of COVID-19 patients requiring supplemental O2 therapy: a prospective controlled non-randomized study 150
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives 146
Neoadjuvant and Adjuvant Systemic Therapies in Loco-Regional Treatments for Hepatocellular Carcinoma: Are We at the Dawn of a New Era? 141
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 140
Long-Term Prognosis among COVID-19 Patients: The Predictive Role Played by Hyperinflammation and Arrhythmic Disorders in Fatal Outcome 140
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma 135
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 135
Sodium-Glucose Co-Transporters Family: Current Evidence, Clinical Applications and Perspectives 134
Directly acting antiviral-based treatment for hcv-infected persons who inject drugs: A multicenter real-life study 134
Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination 133
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 131
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 131
Alcohol Consumption and Liver Metabolism in the Era of MASLD: Integrating Nutritional and Pathophysiological Insights 127
Liver Involvement during SARS-CoV-2 Infection Is Associated with a Worse Respiratory Outcome in COVID-19 Patients 126
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 125
Non-alcoholic Fatty Liver Disease (NAFLD), Type 2 Diabetes, and Non-viral Hepatocarcinoma: Pathophysiological Mechanisms and New Therapeutic Strategies 117
Changes in clinical scenarios, management, and perspectives of patients with chronic hepatitis C after viral clearance by direct-acting antivirals 116
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 112
The Cross-Talk Between the Heart and the Liver: The Involvement of the Mitral Valve as a Novel Actor upon the Ancient Scene of Liver Cirrhosis 95
Myosteatosis is closely associated with sarcopenia and significantly worse outcomes in patients with cirrhosis 94
The transition from NAFLD to MASLD: implications for Diagnosis, Prognosis, and Clinical Management 91
Metabolic Rewiring of Bacterial Pathogens in Response to Antibiotic Pressure—A Molecular Perspective 89
Multidrug-Resistant Infections and Metabolic Syndrome: An Overlooked Bidirectional Relationship 87
The Intestinal Thread of Fate: How the Microbiota Shapes the Story of Liver Disease 63
Totale 5.213
Categoria #
all - tutte 16.236
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.236


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202256 0 0 0 1 3 0 2 1 5 17 5 22
2022/2023250 10 3 13 14 30 30 2 14 95 14 14 11
2023/2024288 29 9 20 36 49 54 3 7 4 14 23 40
2024/2025785 7 15 15 21 127 54 81 76 152 81 79 77
2025/20263.773 196 247 228 147 342 1.861 250 143 140 95 58 66
2026/202761 26 35 0 0 0 0 0 0 0 0 0 0
Totale 5.213